Effects of Alpinumisoflavone and Abyssinone V-4′-Methyl Ether Derived from Erythrina lysistemon (Fabaceae) on the Genital Tract of Ovariectomized Female Wistar Rat

• Published in: Phytotherapy research Vol. 26; no. 7; pp. 1029 - 1036
• Main Authors: Mvondo, M.A., Njamen, D., Tanee Fomum, S., Wandji, J.
• Format: Journal Article
• Language: English
• Published: Chichester, UK John Wiley & Sons, Ltd 01-07-2012; Wiley
• Subjects: Animals; Biological and medical sciences; Erythrina - chemistry; estrogen receptor ligands; estrogenicity; Estrogens - pharmacology; Female; Flavonoids - pharmacology; General pharmacology; Isoflavones - pharmacology; Medical sciences; Ovariectomy; Pharmacognosy. Homeopathy. Health food; Pharmacology. Drug treatments; Plant Extracts - pharmacology; Rats; Rats, Wistar; Receptors, Estrogen - metabolism; uterine growth; Uterus - drug effects; Vagina - cytology; Vagina - drug effects; vaginal stratification; Human; Estrogen receptor; Ovariectomy; Rat; Ligand; Pharmacognosy; Rodentia; Medicinal plant; Vertebrata; Mammalia; Leguminosae; Uterus; vaginal stratification; Dicotyledones; Animal; Angiospermae; Female genital system; Plant origin; Female; Spermatophyta; estrogen receptor ligands; estrogenicity; uterine growth; Hormonal receptor
• ISSN: 0951-418X; 1099-1573
• DOI: 10.1002/ptr.3685

Erythrina lysistemon is an African medicinal plant used as a palliative for problems in women. The crude extract of this plant was shown to exhibit estrogenic effects on the female rat reproductive tract and on cell cuture. Using classic chromatographic methods, two compounds have been isolated as major constituents of this extract: alpinumisoflavone (1) and abyssinone V‐4′‐methyl ether (2). To determine whether both compounds are actives principles accounting for E. lysistemon effects, we applied the classic 3‐day uterotrophic assay. We also carried out a ligand binding assay to determine whether the observed effects are estrogen receptor (ER) mediated. This study showed that whereas compound 1 displayed a fourfold preference for ERα, compound 2 bound ERα and ERβ with a same affinity. The in vivo study showed that compound 1 increased the uterine wet weight by 182.23% (p < 0.01) and 71.79% (p < 0.05) at doses of 0.1 and 1 mg/kg BW/day respectively. The uterine epithelium thickened dose‐dependently. Vaginal epithelial height also increased by 369.97 and 226.76% respectively (p < 0.01). Compound 2 acted only on the vagina and increased vaginal epithelial height by 244.56% (p < 0.01) at 1 mg/kg BW/day. These results suggest that compounds 1 and 2 are endowed with estrogenic properties accounting, at least in part, for E. lysistemon effects. Copyright © 2011 John Wiley & Sons, Ltd.